The AMC has developed a Barrett’s esophagus patient registry of 5,000 patients from 16 hospitals in the Amsterdam region. As a part of the collaboration, Cernostics will use the patient registry to complete clinical validation studies of its product TissueCypher: Barrett’s.
TissueCypher is designed to provide risk prediction for the development of esophageal cancer in Barrett’s esophagus patients.
More Articles on Gastroenterology:
4 Things to Know About Diet as IBS Therapy
14 Colonoscopy Quality Indicators to Consider
9 Things to Know About C. difficile Infection Diagnosis
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
